Literature DB >> 24667024

Event recorder monitoring to compare the efficacy of a left versus biatrial lesion set in patients undergoing concomitant surgical ablation for atrial fibrillation.

Simon Pecha1, Friederike Hartel2, Teymour Ahmadzade3, Muhammet Ali Aydin2, Stephan Willems2, Hermann Reichenspurner3, Florian Mathias Wagner3.   

Abstract

OBJECTIVES: Various lesion sets and subsequent success rates have been reported in patients receiving concomitant surgical ablation for atrial fibrillation. However, most of these results have been obtained by discontinuous monitoring. We report results using continuous event recorder rhythm monitoring to compare more accurately the efficacy of a left versus biatrial lesion set to treat patients with persistent atrial fibrillation.
METHODS: Between July 2008 and December 2011, 66 patients with persistent or long-standing persistent atrial fibrillation underwent concomitant surgical atrial fibrillation ablation with a biatrial lesion set and subcutaneous event recorder implantation. The results and outcomes were compared with a propensity score-matched cohort of 66 patients with a left atrial lesion set and event recorder implantation. Event recorder interrogation was performed at 3, 6, and 12 months follow-up.
RESULTS: The mean patient age was 70.2±7.4 years, and 70.3% were male. No major ablation-related complications occurred. One-year survival was 94.8% with no statistically significant differences between the 2 groups. The overall rate of freedom from atrial fibrillation was 57.3% and 64.4% after 3 and 12 months follow-up, respectively. Three months postoperatively, patients in the biatrial group had a slightly higher rate of freedom from atrial fibrillation (63.6% vs 52.3% P=.22), but it did not reach statistical significance. At 12 months follow-up, a statistically significant higher rate of freedom from atrial fibrillation was observed in patients with a biatrial lesion set (74.4% vs 55.8%; P=.026). The mean atrial fibrillation burden in all patients was 15.1%±12.5% in the biatrial group and 21.2%±14.4% in the left atrial group 12 months postoperatively (P=.03).
CONCLUSIONS: Continuous rhythm monitoring by subcutaneous event recorder implantation was safe and feasible. In patients undergoing biatrial ablation, a statistically significant higher rate of freedom from atrial fibrillation was observed at 12 months follow-up.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24667024     DOI: 10.1016/j.jtcvs.2014.02.061

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Implantable loop recorder monitoring after concomitant surgical ablation for atrial fibrillation (AF): insights from more than 200 continuously monitored patients.

Authors:  Simon Pecha; Muhammet Ali Aydin; Teymour Ahmadzade; Friederike Hartel; Boris Hoffmann; Daniel Steven; Stephan Willems; Hermann Reichenspurner; Florian Mathias Wagner
Journal:  Heart Vessels       Date:  2015-08-29       Impact factor: 2.037

Review 2.  Biatrial versus Isolated Left Atrial Ablation in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Authors:  Hongmu Li; Xifeng Lin; Xun Ma; Jun Tao; Rongjun Zou; Songran Yang; Haibo Liu; Ping Hua
Journal:  Biomed Res Int       Date:  2018-04-29       Impact factor: 3.411

3.  Concomitant surgical ablation for atrial fibrillation (AF) in patients with significant atrial dilation >55 mm. Worth the effort?

Authors:  Simon Pecha; Samer Hakmi; Irina Subbotina; Stephan Willems; Hermann Reichenspurner; Florian Mathias Wagner
Journal:  J Cardiothorac Surg       Date:  2015-11-14       Impact factor: 1.637

4.  Long-term results of minimally invasive stand-alone bi-atrial surgical ablation with a bipolar ablation device for persistent and longstanding persistent AF: a single-center case series of 91 patients.

Authors:  Vilius Janusauskas; Lina Puodziukaite; Vyte Valerija Maneikiene; Gitana Zuoziene; Greta Radauskaite; Greta Burneikaite; Robertas Stasys Samalavicius; Sigita Aidietiene; Kestutis Rucinskas; Audrius Aidietis
Journal:  J Cardiothorac Surg       Date:  2016-02-02       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.